Syndax appoints Aaron A. Ondrey CFO; Keith A. Goldan to retire

SNDX•2026-11-02

Syndax Pharmaceuticals appointed Aaron A. Ondrey chief financial officer, while Keith A. Goldan will retire as CFO and remain through the end of 2026.

1. CFO transition

Syndax Pharmaceuticals appointed Aaron A. Ondrey chief financial officer. Keith A. Goldan will retire as CFO and remain through the end of 2026.

Syndax appoints Aaron A. Ondrey CFO; Keith A. Goldan to retire

1. CFO transition

Related News

D.R. Horton grants executive chairman David Auld 27,390 restricted stock units

Texxon delays fiscal 2026 annual report, needs more time to prepare financial statements

Upwork raises 2026 adjusted EBITDA outlook to $236 million-$240 million

Enphase Energy CEO Badrinarayanan Kothandaraman reports acquisition of $267,514 in common shares

Black Stone Minerals Q3 adjusted core profit eases past estimates